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DNMT1 Stability Is Regulated
by Proteins Coordinating Deubiquitination
and Acetylation-Driven Ubiquitination
Zhanwen Du, Jing Song, Yong Wang,
Yiqing Zhao,
Shuming Yang, Hung-Ying Kao,7 Yan Xu,6,8 Joseph Willis,
David Sedwick, Robert M. Ewing, Zhenghe Wang

Kishore Guda,
Sanford D. Markowitz,

DNA methyltransferase 1 (DNMT1) is the primary enzyme that maintains DNA methylation. We describe a
previously unknown mode of regulation of DNMT1 protein stability through the coordinated action of an
array of DNMT1-associated proteins. DNMT1 was destabilized by acetylation by the acetyltransferase
Tip60, which triggered ubiquitination by the E3 ligase UHRF1, thereby targeting DNMT1 for proteasomal
degradation. In contrast, DNMT1 was stabilized by histone deacetylase 1 (HDAC1) and the deubiquitinase
HAUSP (herpes virus–associated ubiquitin-specific protease). Analysis of the abundance of DNMT1 and
Tip60, as well as the association between HAUSP and DNMT1, suggested that during the cell cycle the
initiation of DNMT1 degradation was coordinated with the end of DNA replication and the need for DNMT
activity. In human colon cancers, the abundance of DNMT1 correlated with that of HAUSP. HAUSP
knockdown rendered colon cancer cells more sensitive to killing by HDAC inhibitors both in tissue
culture and in tumor xenograft models. Thus, these studies provide a mechanism-based rationale for
the development of HDAC and HAUSP inhibitors for combined use in cancer therapy.
INTRODUCTION

DNA methylation is involved in key biological processes including dif
ferentiation, imprinting, and X chromosome inactivation (1). Failure to
maintain proper DNA methylation results in developmental disorders
as well as cancer (2). DNA methyltransferases (DNMTs) 3a and 3b are
required for de novo DNA methylation, whereas DNMT1 is involved in
the maintenance of DNA methylation patterns from parental cells to prog
eny cells (3). During DNA replication, DNMT1 is recruited to replication
forks through its interaction with proliferating cell nuclear antigen
(PCNA) (4). UHRF1 [ubiquitin like with plant homeodomain (PHD)
and ring finger domains 1; also called nuclear protein of 95 kD (NP95)
and inverted CCAAT box binding protein of 90 kD (ICBP90)] recognizes
hemimethylated DNA templates and tethers DNMT1 to replication forks
to methylate newly synthesized DNA strands (5, 6). UHRF1 also contains
a RING domain with ubiquitin E3 ligase activity that mediates ubiquiti
nation of itself and histone H3 (7, 8). In addition to PCNA and UHRF1,
DNMT1 interacts with histone deacetylases (HDACs) (9, 10). HDACs

are generally believed to be recruited by DNMT1 and UHRF1 to repress
gene expression or to form heterochromatin structures (11). However,
Zhou et al. recently demonstrated that HDAC inhibitors induce degrada
tion of DNMT1 (12), suggesting that HDACs may be directly involved in
regulating DNMT1 stability.
Mounting evidence suggests that tumor development can be sup
pressed by maintenance of the proper abundance of DNMT1. Mice that
undergo transient inactivation of DNMT1 during embryogenesis suffer
global loss of imprinting and develop widespread tumors in adulthood
(13). Conversely, overexpression of DNMT1 transforms NIH 3T3 cells
(14), and DNMT1 abundance is increased in many cancer types (15).
Furthermore, earlier studies suggested that the increased DNMT1 abun
dance seen in cancers is largely due to dysregulation of DNMT1 protein
stability rather than higher messenger RNA (mRNA) abundance (16, 17).
Thus, these observations support the premise that fine tuning DNMT1
abundance through posttranslational regulation is important in suppressing
tumorigenesis. However, the mechanisms underlying DNMT1 regulation
are poorly understood. Here, we provide support for a model of regula
tion of DNMT1 abundance and report how an array of interacting pro
teins can coordinately regulate stability or degradation of this critical
enzyme by respectively controlling its deubiquitination and its acetylation
driven ubiquitination.
RESULTS

DNMT1 associates with the deubiquitinase HAUSP
To identify DNMT1 associated proteins, we generated 3xFlag tagged
DNMT1 knock in cells, using recombinant adeno associated virus
(rAAV) mediated homologous recombination to place three Flag epitope
tag sequences (18) at the C terminus of endogenous DNMT1 protein (fig.
S1, A and B). Antibodies directed against Flag immunoprecipitated a pro
tein of ~130 kD from 3xFlag tagged DNMT1 knock in cells, but not from
knock in cells harboring endogenously Flag tagged Mre11 protein (Fig.

002

1A). Analysis by mass spectrometry (MS) identified the protein as HAUSP
(herpes virus associated ubiquitin specific protease; also known as USP7)
(fig. S2). This interaction was validated through reciprocal immuno
precipitation (Fig. 1, B and C) and by demonstrating nuclear colocalization
of DNMT1 and HAUSP (fig. S3A). HAUSP specifically interacts with
DNMT1 and does not coimmunoprecipitate with DNMT 3b (Fig. 1D and
fig. S1C). Using a series of DNMT1 deletion constructs, we determined that
DNMT1 interaction with HAUSP requires a region encompassing the zinc
finger and the two BAH (bromo adjacent homology) domains (fig. S3, B
and C).

teins directly deubiquitinated DNMT1 in vitro (Fig. 1H and fig. S4E).
Experimental controls further showed that (i) a HAUSP C223S (active site)
mutant could not remove ubiquitin moieties from DNMT1 (Fig. 1H), and
(ii) overexpressed HAUSP failed to deubiquitinate a DNMT1 mutant
lacking the HAUSP interaction domain (DNMT1D) (fig. S4, C and D).
A HAUSP knockout DLD1 cell line, which lacks fully functional p53,
was engineered for this study, because the HCT116 HAUSP knockout cells
generated by Cummins et al. (19) exhibited increased p53 abundance,
which we speculate may be why these cells undergo senescence and stop
growing after a few passages.

HAUSP deubiquitinates DNMT1 and protects
it from proteasomal degradation

Acetylation of DNMT1 is directly involved in its
proteasomal degradation

HAUSP is particularly interesting because it deubiquitinates MDM2,
FOXO4, PTEN, and Claspin (19 23). Thus, we proceeded to determine
whether HAUSP stabilizes DNMT1 through deubiquitination to protect it
from proteasomal degradation. First, we showed that knockout of HAUSP
in DLD1 colorectal cancer cells or knockdown of HAUSP in RKO colo
rectal cancer cells and human embryonic kidney (HEK) 293 cells led to
reduced DNMT1 abundance (Fig. 1E and fig. S4, A and B), indicating
that HAUSP regulates DNMT1 protein stability in both normal and cancer
cells. Furthermore, reconstitution of HAUSP expression in knockout cells
restored DNMT1 abundance to an extent comparable to that in parental
cells (Fig. 1E), suggesting that loss of HAUSP is the sole cause of DNMT1
instability. Second, DNMT1 ubiquitination was increased in the HAUSP
knockout cells (Fig. 1F), whereas overexpression of HAUSP led to deubiq
uitination of DNMT1 (Fig. 1G). Third, purified HAUSP recombinant pro

In our search for factors that might oppose the effect of HAUSP on
DNMT1 proteasomal degradation, we noted that HDAC inhibitors induce
ubiquitination mediated proteasomal degradation of DNMT1 (12). We
subsequently found that the HDAC inhibitor MS 275 directly destabilizes
DNMT1 by enhancing its ubiquitination (Fig. 2, A and B) but does not
appear to decrease its gene transcription (fig. S5A). Furthermore, loss of
HAUSP combined with inhibition of HDAC activity had a synergistic
effect on DNMT1 protein stability, because treatment of HAUSP knock
out cells with various HDAC inhibitors reduced DNMT1 abundance to
nearly undetectable amounts (Fig. 2A and fig. S5B). Moreover, inhibition
of HDAC activity induced more DNMT1 ubiquitination in HAUSP
knockout cells than in comparably treated wild type cells (Fig. 2B).
We then showed that acetylation of DNMT1 plays a direct role in this
process. Inhibition of HDAC activity increased DNMT1 acetylation (Fig.
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2C). The functional importance of DNMT1 acetylation was then demon
strated by showing that inhibition of HDAC activity failed to induce deg
radation of a DNMT1 mutant in which the four previously identified
acetylated lysines (24, 25) were altered to arginines (Fig. 2D).
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Fig. 2. Inhibition of HDAC1 mediated DNMT1 deacetylation promotes
DNMT1 proteasomal degradation. (A) Knockout of HAUSP potentiates
HDAC inhibitor (HDACi) induced DNMT1 degradation. Parental or
HAUSP KO DLD1 cells were treated or not with 5 mM HDACi MS 275
for 72 hours and cell lysates were blotted with the indicated antibodies.
(B) HDAC inhibition induces DNMT1 ubiquitination. HAUSP WT or KO
cells were treated with or without HDACi for 24 hours and MG132 for 12
hours before being harvested to make cell lysates. DNMT1 immunopre
cipitates were blotted with an antibody against ubiquitin. Because the
abundance of DNMT1 in the HAUSP KO cells is lower than in WT cells,
more KO cells were used than WT cells to obtain equal amounts of pre
cipitated DNMT1 proteins. (C) DNMT1 is acetylated after HDACi treat
ment. DNMT1 immunoprecipitates from cells treated with HDACi were
blotted with an antibody against acetylated lysine (Ac K). (D) A DNMT1
acetylation site mutant is resistant to HDACi induced degradation. HEK
293 cells were transfected with WT DNMT1 or a DNMT1 mutant lacking
four known acetylation sites (K173R, K1113R, K115R, and K117R) and
treated with MS 275 for 48 hours and with CHX for 24 hours. Cell lysates
were blotted with the indicated antibodies. (E) Knockdown of HDAC1
decreases the abundance of DNMT1. RKO cells were treated with the
indicated concentration of doxycycline (Dox) for 48 hours to induce ex
pression of an shRNA directed against HDAC1. Western blots were per
formed with the indicated antibodies. (F) Knockdown of HDAC1 leads to
increased acetylation of DNMT1. RKO cells expressing an inducible
HDAC1 shRNA were treated with or without Dox (4 mg/ml) for 36 hours
and then with MG132 for 12 hours. DNMT1 immunoprecipitates were
blotted with an antibody against Ac K. Cell lysates were also blotted with
antibodies against HDAC1 and b actin. See fig. S11 for bar graphs and
statistical analyses.
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Because MS 275 is an HDAC1 specific inhibitor and because HDAC1
associates with DNMT1 (9), we set out to determine whether HDAC1
mediated deacetylation protects DNMT1 from degradation. First, we
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Fig. 3. Acetylation of DNMT1 by Tip60 promotes its degradation. (A)
DNMT1 interacts with Tip60. (B) Tip60 acetylates DNMT1. (C) Overex
pression of Tip60 leads to increased ubiquitination of DNMT1. Antibody
against Myc immunoprecipitates from HEK 293 cells transfected with the
indicated plasmids were immunoblotted with antibody against Flag to
detect Tip60 (A), antibody against acetylated lysine to detect DNMT1
acetylation (B), or antibody against HA to detect ubiquitin (C). (D) Over
expression of Tip60 reduced the abundance of endogenous DNMT1.
HEK 293 cells were transfected with either control plasmid or Tip60. Cell
lysates were blotted with antibody against DNMT1 or antibody against
Flag to detect Tip60. b Actin was used as the loading control. (E) Knock
down of Tip60 leads to increased abundance of endogenous DNMT1.
Tip60 Flag tagged knock in HCT116 cells were transfected with control
siRNA or two independent siRNAs against Tip60. Western blots were
used to quantify DNMT1 and Tip60 with antibodies against DNMT1
and Flag, respectively. (F) Knockdown of Tip60 blocks HDACi induced
DNMT1 degradation. Cells were transfected with control siRNA or siRNAs
against Tip60 and treated with or without MS 275. Western blots were per
formed with the indicated antibodies. See fig. S11 for bar graphs and sta
tistical analyses.
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cancer cells led to reduced DNMT1 abundance, consistent with a similar
observation made in a breast cancer cell line (Fig. 2E) (12). Knockdown
of HDAC1 led to increased DNMT1 acetylation (Fig. 2F). These data
suggest that HDAC1 deacetylates DNMT1, thus protecting it from pro
teasomal degradation.
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Upon examination of potential acetyltransferases that could acetylate
DNMT1, our attention was drawn to Tip60 because of its ability to form
complexes with UHRF1 (also known as NP95), which associates with
DNMT1 (26). We demonstrated that Tip60 bound not only to UHRF1
but also to DNMT1 (Fig. 3A) and that overexpression of Tip60 led to
increased DNMT1 acetylation and ubiquitination (Fig. 3, B and C). In
support of the premise that Tip60 mediated acetylation regulates DNMT1
stability, overexpression of Tip60 also led to reduced abundance of en
dogenous DNMT1 (Fig. 3D). Conversely, knockdown of Tip60 by two
different small interfering RNAs (siRNAs) resulted in increased DNMT1
abundance (Fig. 3E). Because commercially available antibodies directed
against Tip60 were not optimal for Western blot analysis, we generated a
3xFlag tagged Tip60 knock in HCT116 cell line (fig. S1D).
Furthermore, knockdown of Tip60 blocked DNMT1 degradation
induced by inhibition of HDAC activity (Fig. 3F). Therefore, Tip60 en
ables HDAC inhibitor induced degradation of DNMT1 by mediating
DNMT1 acetylation.

Tip60

Flag-UHRF1

Fig. 4. The E3 ligase UHRF1 ubiquitinates DNMT1. (A) HDAC inhibition
enhances DNMT1 interaction with UHRF1. HEK 293 cells were trans
fected with plasmids expressing Myc DNMT1 and Flag UHRF1 and treated
with or without MS 275 for 24 hours. Myc DNMT1 immunoprecipitates were
blotted with the indicated antibodies. (B and C) HDAC inhibition enhances
the interaction of endogenous DNMT1 and UHRF1. Cells were treated with
or without MS 275 and UHRF1 (B) or DNMT1 (C) immunoprecipitates were
blotted with the indicated antibodies. (D) UHRF1 ubiquitinates DNMT1.
HEK 293 cells were transfected with the indicated plasmids. Antibodies
against Myc immunoprecipitates were blotted with antibody against HA
to detect ubiquitinated DNMT1. Myc DNMT1D, DNMT1 mutant lacking
the HAUSP interacting domain. UHRF1DRING, UHRF1 with a RING domain
deletion. (E) Knockdown of UHRF1 blocks HDACi induced DNMT1 degra
dation. HEK 293 cells were transfected with control siRNA or siRNAs
against UHRF1 and treated with or without MS 275. Western blotting was
performed with the indicated antibodies. (F) Overexpression of UHRF1
leads to degradation of a DNMT1 mutant lacking the HAUSP interacting
domain (DNMT1D). Full length DNMT1 or DNMT1D was cotransfected into
HEK 293 cells with the indicated expression vectors. Cell lysates were
blotted with the indicated antibodies. (G) DNMT1, HAUSP, UHRF1, HDAC1,
and PCNA associate with Tip60. Flag tagged Tip60 immunoprecipitates
were blotted with the indicated antibodies. See fig. S11 for bar graphs
and statistical analyses.

UHRF1 mediates ubiquitination of DNMT1
We postulated that acetylation of DNMT1 might promote its ubiquitina
tion by recruiting or enhancing its interaction with an E3 ligase. As noted
above, the RING domain containing E3 ligase UHRF1 associates with
DNMT1 (5, 6, 27); therefore, we tested whether acetylation of DNMT1
enhances its interaction with UHRF1. HDAC inhibition increased the
interaction between endogenous and transfected DNMT1 and UHRF1
(Fig. 4, A to C). Furthermore, overexpression of UHRF1 led to increased
ubiquitination of DNMT1 (Fig. 4D). However, knockdown of UHRF1
did not affect DNMT1 abundance (fig. S6A), but UHRF1 mediated
ubiquitination was required for HDAC inhibitor induced degradation of
DNMT1. In addition, knockdown of UHRF1 by three different siRNAs
blocked HDAC inhibitor induced degradation of DNMT1 (Fig. 4E). Con
versely, overexpression of UHRF1 reduced the abundance of a DNMT1
mutant lacking the HAUSP interaction domain (DNMT1D) (Fig. 4F). Fur
thermore, overexpression of UHRF1 DRING did not decrease the abun
dance of DNMT1D (Fig. 4F), showing that this regulation requires the E3
ligase activity of UHRF1. Overexpression of UHRF1 had no effect on the
abundance of full length DNMT1 (Fig. 4F). This observation is consistent
with a requirement of HAUSP to interact with full length DNMT1 to an
tagonize UHRF1 mediated ubiquitination of DNMT1.

DNMT1, HAUSP, UHRF1, Tip60, HDAC1,
and PCNA interact with each other
Results to this point demonstrated that DNMT1 abundance can be
increased by interaction with HAUSP and decreased by interaction with
UHRF1 and Tip60. We wanted to determine whether the proteins that
regulate DNMT1 abundance also interacted with PNCA, a factor sup
porting possessive DNA replication that interacts with proteins at DNA
replication forks. Immunoprecipitation of Tip60 not only coprecipitated
DNMT1, HAUSP, UHRF1, and HDAC1, but also PCNA (Fig. 4G). In addi
tion, these protein interactions were also validated by immunoprecipitation
of both UHRF1 and PCNA (fig. S6, B and C). Moreover, the specificity
of HDAC inhibitors for DNMT1 was supported by the observation that
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they induced DNMT1 degradation without affecting the intracellular
abundance of the other components (HAUSP, UHRF1, HDAC1, Tip60,
and PCNA) in the complex (fig. S5C).

Tip60 and HAUSP appear to regulate DNMT1
protein stability during the cell cycle
Although we had shown that a complex of proteins regulated DNMT1
stability, we had not shown that these interactions tracked with any cel
lular function. Therefore, we analyzed the temporal profile of DNMT1
abundance throughout the cell cycle to determine whether the interactions
and specific abundance of the proteins regulating DNMT1 abundance
changed during cell replication processes. Cells were synchronized at early
S phase by sequential thymidine and aphidicolin blocks and then released.
The abundance of DNMT1 started to decrease at either late S phase or G2
(5 hours after release) and the reduced abundance of DNMT1 persisted
into the G1 phase of the next cell cycle (fig. S7, A and B). Furthermore,
the abundance of Tip60 increased as the cell cycle progressed, and the
abundance of DNMT1 and Tip60 appeared to be inversely correlated dur
ing the cell cycle. These data provide another line of evidence suggesting
that Tip60 mediated DNMT1 acetylation triggers DNMT1 degradation.
Furthermore, the abundance of UHRF1 was decreased between 11 and
13 hours but was restored by 24 hours (fig. S7, A and B). In contrast, the
abundance of HAUSP, HDAC1, and PCNA remained constant through
out the cell cycle (fig. S7A). Given that HAUSP protects DNMT1 from
degradation and that physical interaction between the two proteins is re
quired for HAUSP to stabilize DNMT1, we tested whether HAUSP dis
sociates from DNMT1 during S phase before DNMT1 abundance is
decreased by degradation. Less DNMT1 coprecipitated with HAUSP at
both 3 and 5 hours after release relative to time point 0 (fig. S7, C to F),
suggesting that HAUSP is not associated with DNMT1 during mid or late
S phase. Furthermore, the amount of UHRF1 associated with DNMT1
increased with cell cycle progression (fig. S7, C and D), suggesting that
increased interaction between UHRF1 and DNMT1 during late S phase
facilitates DNMT1 degradation.

The abundance of DNMT1 and HAUSP
correlates in human colon cancer

through which the abundance of DNMT1 is increased in human cancers
and that HAUSP could be therapeutically targeted in such tumors.

HAUSP knockout cells are more sensitive
to HDAC inhibitors
To explore whether loss of HAUSP can be exploited as a cancer therapy
strategy, we treated wild type and HAUSP knockout cells with HDAC
inhibitors, which induced 5 to 10 times as many apoptotic cells in
HAUSP knockout cells relative to wild type cells (Fig. 6A and fig. S9A)
(P < 0.001, t test). Tested HDAC inhibitors included MS 275, LBH589,
SAHA (suberoylanilide hydroxamic acid), and TSA (trichostatin A) (Fig.
6A and fig. S9A). Furthermore, HDAC inhibition increased the number
of apoptotic cells (sub G1 cells) (Fig. 6B and fig. S9B) and increased the
abundance of apoptotic cell markers including cleaved caspases 3, 6, and
9, and poly(adenosine diphosphate ribose) polymerase (PARP) (Fig. 6C and
fig. S9C). In contrast, HDAC inhibition predominantly induced G2 M
arrest in wild type cells (Fig. 6B and fig. S9B), and reconstituting the
HAUSP knockout cells with ectopically expressed HAUSP suppressed ap
optosis induced by HDAC inhibitors (Fig. 6A and fig. S9A). Furthermore,
degradation of DNMT1 was the major cause of cell death, because ectopic
overexpression of DNMT1 in the HAUSP knockout cells partially rescued
HDAC inhibitor induced apoptosis (Fig. 6D). Moreover, HAUSP knockout
cells were more sensitive to growth arrest caused by MS 275 (Fig. 6E)
when grown in cell culture (P < 0.001, t test).
Finally, in a tumor xenograft model, treating HAUSP knockout cells with
the HDAC inhibitor MS 275 led to almost complete suppression of xeno
graft tumor formation (Fig. 6, F and G), even though HAUSP knockout
cells grew slower as xenograft tumors than the wild type cells. In contrast,
HDAC inhibition did not affect wild type tumor growth. Together, these
results demonstrated that HAUSP deficient colorectal cancer cells are more
sensitive to HDAC inhibitors and provide a compelling rationale for tar
geting both HAUSP and HDAC1 in combined cancer therapy strategies.

DNA methylation in the imprinted H19 locus
is impaired in the HAUSP knockout cells
Given that DNMT1 is the maintenance enzyme for DNA methylation and
that its abundance is reduced in the HAUSP knockout cells, we set out to
determine whether DNA methylation status was altered in knockout cells.
We first used pyrosequencing to quantify methylated CpG amounts in the
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Because of the role of DNMT1 in maintaining epigenetic methylation
required to silence genes involved in development and cancer, modula
tion of its stability and degradation may be potential
A
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therapeutic targets. To determine the clinical rele
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5
vance of regulation of DNMT1 stability by HAUSP,
we examined the abundance of DNMT1 and HAUSP
4
in human colon cancer tissues with immunohisto
chemical (IHC) approaches. Ten colon tumor and
3
normal pairs were examined. Five of these tumors
showed higher abundance of DNMT1 relative to
2
matched normal colon tissues, and these tumors also
stained strongly with the antibody against HAUSP
1
(Fig. 5, A and B). Overall, the abundance of HAUSP
correlated with the abundance of DNMT1 in these tu
0
mors (Fig. 5B; R2 0.84). In normal colon, both
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DNMT1 and HAUSP were predominantly found in
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the proliferative crypt epithelial cells (fig. S8A).
Furthermore, IHC staining of colon cancer cells could Fig. 5. The abundance of DNMT1 correlates with that of HAUSP in colon cancer cells. (A) DNMT1
be completely blocked by competition with either and HAUSP IHC staining of two representative tumors. Formalin fixed paraffin embedded sections
DNMT1 peptides or recombinant HAUSP proteins of colon adenocarcinomas were stained with antibodies against HAUSP and DNMT1. (B) Cor
(fig. S8B), indicating that the IHC staining was specific relation of IHC intensity between DNMT1 and HAUSP staining in 10 colon carcinomas (R2 0.84).
to the target proteins. These results suggest that in Ten low grade, moderately differentiated adenocarcinomas were examined and the intensity of
creased abundance of HAUSP may be a mechanism DNMT1 staining was plotted against the intensity of HAUSP staining for each tumor.
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transfecting equal amounts of the targeting vector, pHelper, and pRC
plasmids. Viruses were harvested 72 hours after transfection. RKO or
DLD1 cells were infected with the targeting viruses and selected with
geneticin for 20 days. The geneticin resistant clones were then screened
for homologous recombination by genomic PCR with primers derived
from the neomycin resistance gene (5′ GTTGTGCCCAGTCATAGCCG
3′) and the upstream region of the left homologous arm. After the first
allele was targeted, the neomycin resistance gene was excised by Cre re
combinase. In the case of HAUSP knockout, two independently targeted
clones were retargeted to obtain homozygous knockout clones.

In-gel digestion
Each gel piece was cut into 0.5 mm cubes and destained by repeated ad
dition of NH4CO3/acetonitrile (1:1, v/v) solution until most of the dye
was extracted from the gel cubes. The gel cubes were dried with 100%
acetonitrile followed by vacuum centrifugation. The dried gel cubes were
then reduced by 20 mM dithiothreitol (DTT) and alkylated by 55 mM
iodoacetamide. After removal of excess DTT and iodoacetamide by
100 mM NH4CO3 and 100 mM NH4CO3/acetonitrile (1:1, v/v) solution,
the gel cubes were dried with 100% acetonitrile followed by vacuum cen
trifugation. For one gel piece, 10 µl of the trypsin solution (0.2 µg/µl;
Promega, PR V5111) was added to rehydrate the gel plugs and incubated
at 37°C overnight. The digestion solution was collected and combined with
more extraction buffer (60% acetonitrile/5% formic acid) containing ex
tracted peptides after the vortex and sonication steps. The final volume was
reduced to 10 µl by vacuum centrifugation and addition of 0.1% formic acid.

Mass spectrometric analyses
Separation of peptides by capillary liquid chromatography was performed with
a Dionex Ultimate 3000 capillary high performance liquid chromatography
(HPLC) system. MS analyses of samples were performed with a Thermo
Finnegan LTQ Orbitrap mass spectrometer with an octopole collision cell.

Mass spectrometric data analysis
Raw LC MS/MS data were processed by Mascot version 2.2.0 (Matrix
Science). The raw data were searched against the human International
Protein Index database (released in 2009 and containing 74,017 protein
sequences) with fixed modification carbamidomethyl (C) and variable
modification oxidation (M). Peptides were filtered at a significance
threshold of P < 0.05 (Mascot).

Generation of stable cell lines conditionally inducible
for expression of DNMT1 in HAUSP knockout cells

HDAC inhibition increased DNMT1 mRNA expression driven by the cyto
megalovirus promoter in the construct.

Immunofluorescence staining
DNMT1 3xFlag tagged knock in RKO cells were fixed with 4% para
formaldehyde for 30 min at room temperature, permeabilized with
0.2% Triton X 100 at room temperature for 5 min, and then blocked
with Image iT FX signal enhancer (Invitrogen) at room temperature for
30 min. Immunofluorescence staining was performed with mouse an
tibody against Flag, rabbit antibody against HAUSP, and Alexa Fluor
488 conjugated antibody against mouse and Alexa Fluor 594 conjugated
secondary antibody against rabbit (Invitrogen). Nuclei were stained with
DAPI (4′,6 diamidino 2 phenylindole; 1 mg/ml) at room temperature for
20 min. Images were captured with an inverted Leica DM IRE2 micro
scope and a Leica TCS SP2 AOBS filter free UV/spectral confocal laser
scanner.

In vitro deubiquitination assay
Hexahistidine tagged wild type HAUSP and HAUSP C223S mutant
proteins were expressed in Escherichia coli BL21 cells and purified
with Ni NTA beads. Ubiquitinated DNMT1 was incubated with 100 ng
of either wild type or mutant HAUSP protein in a deubiquitination buffer
[50 mM tris HCl (pH 8.0), 50 mM NaCl, 1 mM EDTA, 10 mM dithiothreitol
(DTT), and 5% glycerol] for 2 hours at 37°C.

Immunohistochemistry
Paraffin embedded human tissues were deparaffinized in xylene twice for
7 min. Antigen retrieval was performed by boiling the sample in a steamer
for 20 min. Samples were blocked with Dako Serum Free Protein Block
for 20 min and then incubated with primary antibodies at 4°C overnight.
The sections were stained with secondary antibody for 30 min at room
temperature and then stained with an EnVision HRP kit (Dako). The im
munohistochemical staining was reviewed blindly and independently by
two individuals. Stained sections were classified according to the intensity
of staining and the percentage of cells showing HAUSP or DNMT1 stain
ing. This was assessed in a semiquantitative manner with assignment of
staining range graded from 1+ to 4+.

Flow cytometry
Cells were collected by trypsinization, fixed in 70% ethanol overnight at
4°C, and stained with propidium iodide. Fluorescence was measured with
an EPICS XL MCL flow cytometer.

Reverse transcription PCR

The pcDNA6/TR plasmid (Invitrogen) was transfected into DLD1
HAUSP knockout cells. After selection with blasticidin, several TR stable
colonies were transfected with pcDNA4/TO/Myc His DNMT1 plasmid.
Blasticidin and zeocin resistant colonies were induced with tetracycline,
and the abundance of DNMT1 was determined with antibodies directed
against Myc.

Total RNAs were isolated from 1 million cells with the Qiagen RNeasy
Mini Kit according to the manufacturer’s instructions, and complementary
DNAs (cDNAs) were synthesized with the SuperScript III First Strand
Synthesis System (Invitrogen). Primers (5′ gtgggggactgtgtctctgt 3′ and
5′ accaactcggtacaggatgc 3′) were used to PCR amplify DNMT1.

Western blotting

Cell cycle synchronization

Cells were lysed in radioimmunoprecipitation assay buffer with complete
protease inhibitor mixture [50 mM tris HCl (pH 8.0), 0.5% Triton X 100,
0.25% sodium deoxycholate, 150 mM sodium chloride, 1 mM EDTA,
1 mM sodium orthovanadate, 50 mM NaF, 80 mM b glycerophosphate, and
20 mM sodium pyrophosphate]. Western blots were performed essentially
as described (32), and multiple replicates of each blot were performed. For
Fig. 2D, protein translation was blocked with cycloheximide (CHX) for
24 hours before cells were harvested, because unlike the endogenous
DNMT1 promoter, which is not affected by HDAC inhibitor treatment,

HCT116 cells were treated with 2.5 mM thymidine for 18 hours, washed
with phosphate buffered saline (PBS) twice, and then grown in complete
medium for 8 hours. Cells were then treated with aphidicolin (2 mg/ml)
for 15 hours. At time 0, the cells were washed with PBS to release the
block and grown in complete medium.

siRNA knockdown of HAUSP, Tip60, and UHRF1
Cells were transfected with 150 pmol of each of the siRNAs below with
the Lipofectamine RNAiMAX transfection reagent (Invitrogen).
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An ON TARGETplus SMARTpool siRNA against HAUSP was purchased
from Dharmacon (target sequence: 5′ AAGCGUCCCUUUAGCAUUA
3; 5′ GCAUAGUGAUAAACCUGUA 3′; 5′ UAAGGACCCUG
CAAAUUAU 3; 5′ GUAAAGAAGUAGACUAUCG 3′).
Two siRNA duplexes for Tip60 were synthesized by Dharmacon:
5′ ACGGAAGGUGGAGGUGGUUdTdT 3′/5′ AACCACCUCCAC
CUUCCGUdTdT 3′; and 5′ GUACGGCCGUAGUCUCAAGdTdT 3′/5′
CUUGAGACUACGGCCGUACdTdT 3′. Three siRNA duplexes against
UHRF1 were purchased from Invitrogen: 5′ UUGUAGUUGAGCAU
GACCACCUGGC 3′/5′ GCCAGGUGGUCAUGCUCAACUACAA 3′;
5′ UAAAUGACGUCCUCCUCCAGCGCCG 3′/5′ CGGCGCUGGAG
GAGGACGUCAUUUA 3′; and 5′ UUCAUCUGGACCACGCCGUU
CUCCG 3′/5′ CGGAGAACGGCGUGGUCCAGAUGAA 3′.

Generation of RKO cells inducibly expressing
a short hairpin RNA against HDAC1
To conditionally induce RNA interference with HDAC1 expression, we
transduced an RKO cell line to harbor a conditional short hairpin RNA
(shRNA) expressing lentivirus construct. This cell line was constructed
following the methods described in (33). The doxycycline inducible sys
tem carried an shRNA construct derived from a sequence provided by
Dharmacon RNA Technologies (mature siRNA sense sequence: 5′
GAAAGUCUGUUACUACUACUU 3′). For these experiments, HEK
293T cells were cotransduced with pLV tTRKRAB red vector and
pLVTHsiGFP, and then RKO cells were multiply transduced (three times)
with the transducing replication defective virus stock carrying the
conditional HDAC1 targeted knockdown vector system. Experiments
were carried out at 2 days after induction of HDAC1 shRNA with dox
ycycline (4 mg/ml) treatment.

Xenograft and HDAC inhibitor treatment
Five million cells were injected subcutaneously and bilaterally into 4 to
6 week old female nude mice (five nude mice in each group). The mice
were randomized to vehicle or MS 275 (15 mg/kg) treatment intra
peritoneally daily. Tumor formation and size were assessed by weekly
caliper measurements. After 28 days, the mice were killed and tumors
were harvested.

Pyrosequencing to quantify LINE-1 and
p16 methylation
Genomic DNA was prepared with the QIAamp DNA Blood Mini Kit.
Bisulfite treatment of the genomic DNA samples was carried out with
the Qiagen EpiTect kit. The methylation status of LINE 1 and p16 was
determined with the pyrosequencing assay (PyroMark MD, Qiagen)
according to the manufacturer’s instructions. Briefly, 150 ng of bisulfate
converted DNA from HCT116 wild type, HCT116 HAUSP / , DLD1 wild
type, DLD1 HAUSP / , and DLD1 HAUSP / with HAUSP reconstitution
was PCR amplified in triplicate in a 50 ml reaction volume with prede
signed biotinylated LINE 1 specific primers that span part of the LINE 1
element, and with p16 specific primers that span a region of +148 to
+161 within the exon 1 of the p16 gene (Qiagen). The amplification
products were then captured with streptavidin Sepharose beads (GE
Healthcare BioSciences) and pyrosequenced with the respective pre
designed sequencing primers per the manufacturer’s instructions (Qiagen).
Next, the individual methylation frequencies of four CpG sites located in
both LINE 1 and p16 amplification products were determined with the
Pyro Q CpG software (Qiagen). The average methylation frequency of
the four CpG sites was then calculated, and the mean frequency of the
triplicate reactions was considered as the overall methylation rate for each
sample.

Quantification of m5dC by LC-MS/MS
About 1 µg of genomic DNA and 10 µl of the internal standard working
mixture solution of cytosine 2,4 13C2 15N3 (10.0 µg/ml) and 5 methyl 2′
deoxycytidine (m5dC) (500 ng/ml) were transferred to a 4 ml glass vial
and dried with nitrogen gas. The residues were dissolved in 30 µl of for
mic acid. The glass vials were sealed with a polytetrafluoroethylene faced
silicone septum with an aluminum crimp cap and heated at 150°C for 3
hours in a dry bath incubator. The glass vials were then cooled, and the
formic acid solution was dried with nitrogen gas at room temperature. The
residue was reconstituted in 100 µl of 5 mM perfluoropentanoic acid aque
ous solution before analysis. The Shimadzu HPLC system has two LC 20AD
pumps and one SIL 20AC autosampler, and a Waters Xterra C18 analytical
column (2.1 × 50 mm, 3.5 µm) with a Waters Xterra guard column (2.1 ×
10 mm). Mobile phase A (MPA) was 5 mM perfluoropentanoic acid in de
ionized water, and mobile phase B (MPB) was 5 mM perfluoropentanoic
acid in acetonitrile. The analytes were eluted by a linear gradient with 5 to
75% MPB from 0 to 7 min, 75 to 5% MPB from 7 to 7.5 min, and 5%
MPB from 7.5 to 13 min. The flow rate was 0.2 ml/min and the injection
amount was 10 µl.
The API 3200 MS/MS mass spectrometer was operated under a posi
tive turbospray ionization condition. Quantification was carried out by
multiple reaction monitoring (MRM) mode with the following settings: mass
transitions: mass/charge ratio (m/z) 112.1 → 95.1 for cytosine, 126.1 → 109.1
for 5 methylcytosine, 117.1 → 99.1 for cytosine 2,4 13C2 15N3 (internal
standard), and 130.1 → 113.2 for m5dC (internal standard); dwell time,
50 ms; curtain gas (CUR), 40; collision gas, 5; ion spray voltage, 5500 V;
source temperature (TEM), 650°C; ion source gas 1 (GS1), 45; ion source
gas 2 (GS2), 50; declustering potential (DP), 50; entrance potential (EP), 8;
collision cell entrance potential (CEP), 12; collision energy (CE), 25; collision
cell exit potential (CXP), 2.0; and unit resolution for both Q1 and Q2. Data
acquisition and peak integration were done with Analyst software (version
1.5) with the IntelliQuan MQII algorithm. The peak area ratios of cytosine
(m/z 112.1 → 95.1) to cytosine 2,4 13C2 15N3 (internal standard, m/z
117.1 → 99.1) were plotted against cytosine concentrations in standard samples
for a linear regression equation with a weighting factor of 1/x2. The cytosine
and 5 methyl cytosine concentrations of the unknown samples were de
termined automatically by the Analyst software from the linear regression
equation after obtaining the peak area ratios from their mass chromatograms.

Bisulfate sequencing of H19 CpG islands
Bisulfite treatment of the genomic DNA samples was carried out with the
Qiagen EpiTect kit according to the manufacturer’s instructions, followed
by PCR amplification with specific primers for H19 promoter region (for
ward: 5′ ATGTAAGATTTTGGTGGAATAT 3′; reverse: 5′ ACAAACT
CACACATCACAACC 3′). The PCR products were gel purified, inserted
into TA cloning vectors (Invitrogen), and sequenced.

Statistical analyses

We applied the t test to compare the means between two groups assuming
unequal variances. For xenograft growth, we performed multivariate anal
ysis of variance (MANOVA) for repeated measurements to determine
whether there was an overall difference of the tumor sizes, as well as
whether there was a difference in development over time of tumor sizes
between the two groups. The Wilcoxon rank sum test was used to analyze
the normalized Western blot data.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/3/146/ra80/DC1
Materials and Methods
Fig. S1. Engineering of DNMT1, DNMT 3b, and Tip60 3xFlag tagged knock in cells.
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